To investigate the significance of the C - terminal Abl actin - binding domain within Bcr / Abl p190 in the development of leukemia / lymphoma in vivo, mutant p190 DNA constructs were used to generate transgenic mice.	"Abl	52	55	Gene_or_gene_product"	"actin	56	61	Gene_or_gene_product"	"Bcr / Abl p190	86	100	Gene_or_gene_product"	"p190	159	163	Gene_or_gene_product"	"[{""token"": ""Abl"", ""start_span"": 52, ""end_span"": 55, ""type"": ""Gene_or_gene_product""}, {""token"": ""actin"", ""start_span"": 56, ""end_span"": 61, ""type"": ""Gene_or_gene_product""}, {""token"": ""Bcr / Abl p190"", ""start_span"": 86, ""end_span"": 100, ""type"": ""Gene_or_gene_product""}, {""token"": ""p190"", ""start_span"": 159, ""end_span"": 163, ""type"": ""Gene_or_gene_product""}]"
IL - 18, originally identified as interferon - gamma inducing factor ( IGIF), is related to the IL - 1 family in terms of its structure as well as its processing, receptor, signal transduction pathway and pro - inflammatory properties.	"IL - 18	0	7	Gene_or_gene_product"	"interferon - gamma inducing factor	34	68	Gene_or_gene_product"	"IGIF	71	75	Gene_or_gene_product"	"IL - 1	96	102	Gene_or_gene_product"	"[{""token"": ""IL - 18"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene_or_gene_product""}, {""token"": ""interferon - gamma inducing factor"", ""start_span"": 34, ""end_span"": 68, ""type"": ""Gene_or_gene_product""}, {""token"": ""IGIF"", ""start_span"": 71, ""end_span"": 75, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 1"", ""start_span"": 96, ""end_span"": 102, ""type"": ""Gene_or_gene_product""}]"
Vascular endothelial growth factor ( VEGF) is an angiogenic stimulator which functions through two endothelial specific tyrosine kinase receptors, Flt - 1 and Flk - 1.	"Vascular endothelial growth factor	0	34	Gene_or_gene_product"	"VEGF	37	41	Gene_or_gene_product"	"Flt - 1	147	154	Gene_or_gene_product"	"Flk - 1	159	166	Gene_or_gene_product"	"[{""token"": ""Vascular endothelial growth factor"", ""start_span"": 0, ""end_span"": 34, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 37, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""Flt - 1"", ""start_span"": 147, ""end_span"": 154, ""type"": ""Gene_or_gene_product""}, {""token"": ""Flk - 1"", ""start_span"": 159, ""end_span"": 166, ""type"": ""Gene_or_gene_product""}]"
In the current article we demonstrate that TnI inhibits both bFGF - stimulated and basal levels of endothelial cell proliferation, and we hypothesize that this inhibition is occurring, at least in part, via an interaction of TnI with the cell - surface bFGF receptor on capillary endothelial cells.	"TnI	43	46	Gene_or_gene_product"	"bFGF	61	65	Gene_or_gene_product"	"TnI	225	228	Gene_or_gene_product"	"bFGF receptor	253	266	Gene_or_gene_product"	"[{""token"": ""TnI"", ""start_span"": 43, ""end_span"": 46, ""type"": ""Gene_or_gene_product""}, {""token"": ""bFGF"", ""start_span"": 61, ""end_span"": 65, ""type"": ""Gene_or_gene_product""}, {""token"": ""TnI"", ""start_span"": 225, ""end_span"": 228, ""type"": ""Gene_or_gene_product""}, {""token"": ""bFGF receptor"", ""start_span"": 253, ""end_span"": 266, ""type"": ""Gene_or_gene_product""}]"
Constitutively active RhoA ( FRTL - 5 - RhoA QL cells) exhibited a fibroblast - like phenotype with organized actin fibers, whereas cells expressing the RhoA negative dominant phenotype ( FRTL - 5 - RhoA N19 cells) present a rounded morphology and lose normal cytoskeletal architecture.	"RhoA	22	26	Gene_or_gene_product"	"RhoA	40	44	Gene_or_gene_product"	"actin	110	115	Gene_or_gene_product"	"RhoA	153	157	Gene_or_gene_product"	"[{""token"": ""RhoA"", ""start_span"": 22, ""end_span"": 26, ""type"": ""Gene_or_gene_product""}, {""token"": ""RhoA"", ""start_span"": 40, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}, {""token"": ""actin"", ""start_span"": 110, ""end_span"": 115, ""type"": ""Gene_or_gene_product""}, {""token"": ""RhoA"", ""start_span"": 153, ""end_span"": 157, ""type"": ""Gene_or_gene_product""}]"
Interestingly, FRTL - 5 - RhoA QL cells express less Tg and TTF - 1 than wild - type FRTL - 5 ( FRTL - 5 - vector) or FRTL - 5 - RhoA N19, suggesting a loss at the differentiation stage.	"RhoA	26	30	Gene_or_gene_product"	"Tg	53	55	Gene_or_gene_product"	"TTF - 1	60	67	Gene_or_gene_product"	"RhoA	129	133	Gene_or_gene_product"	"[{""token"": ""RhoA"", ""start_span"": 26, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""Tg"", ""start_span"": 53, ""end_span"": 55, ""type"": ""Gene_or_gene_product""}, {""token"": ""TTF - 1"", ""start_span"": 60, ""end_span"": 67, ""type"": ""Gene_or_gene_product""}, {""token"": ""RhoA"", ""start_span"": 129, ""end_span"": 133, ""type"": ""Gene_or_gene_product""}]"
This effect is mediated, at least in part, by a decrease in TTF - 1 activity, since transient or stable expression of RhoA QL results in a reduction in the activity of the wild - type Tg promoter as well as an artificial promoter the activation of which depends exclusively on TTF - 1.	"TTF - 1	60	67	Gene_or_gene_product"	"RhoA	118	122	Gene_or_gene_product"	"Tg	184	186	Gene_or_gene_product"	"TTF - 1	277	284	Gene_or_gene_product"	"[{""token"": ""TTF - 1"", ""start_span"": 60, ""end_span"": 67, ""type"": ""Gene_or_gene_product""}, {""token"": ""RhoA"", ""start_span"": 118, ""end_span"": 122, ""type"": ""Gene_or_gene_product""}, {""token"": ""Tg"", ""start_span"": 184, ""end_span"": 186, ""type"": ""Gene_or_gene_product""}, {""token"": ""TTF - 1"", ""start_span"": 277, ""end_span"": 284, ""type"": ""Gene_or_gene_product""}]"
Thrombin and SFLLR activated progelatinase A ( MMP - 2) in the culture medium of human umbilical cord endothelial cells ( HUVECs).	"Thrombin	0	8	Gene_or_gene_product"	"SFLLR	13	18	Gene_or_gene_product"	"progelatinase A	29	44	Gene_or_gene_product"	"MMP - 2	47	54	Gene_or_gene_product"	"[{""token"": ""Thrombin"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Gene_or_gene_product""}, {""token"": ""SFLLR"", ""start_span"": 13, ""end_span"": 18, ""type"": ""Gene_or_gene_product""}, {""token"": ""progelatinase A"", ""start_span"": 29, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}, {""token"": ""MMP - 2"", ""start_span"": 47, ""end_span"": 54, ""type"": ""Gene_or_gene_product""}]"
VEGF165 mediates formation of complexes containing VEGFR - 2 and neuropilin - 1 that enhance VEGF165 - receptor binding.	"VEGF165	0	7	Gene_or_gene_product"	"VEGFR - 2	51	60	Gene_or_gene_product"	"neuropilin - 1	65	79	Gene_or_gene_product"	"VEGF165	93	100	Gene_or_gene_product"	"[{""token"": ""VEGF165"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGFR - 2"", ""start_span"": 51, ""end_span"": 60, ""type"": ""Gene_or_gene_product""}, {""token"": ""neuropilin - 1"", ""start_span"": 65, ""end_span"": 79, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF165"", ""start_span"": 93, ""end_span"": 100, ""type"": ""Gene_or_gene_product""}]"
An intracellular complex containing NRP1 and KDR was immunoprecipitated from EC by anti - NRP1 antibodies only in the presence of VEGF165.	"NRP1	36	40	Gene_or_gene_product"	"KDR	45	48	Gene_or_gene_product"	"anti - NRP1 antibodies	83	105	Gene_or_gene_product"	"VEGF165	130	137	Gene_or_gene_product"	"[{""token"": ""NRP1"", ""start_span"": 36, ""end_span"": 40, ""type"": ""Gene_or_gene_product""}, {""token"": ""KDR"", ""start_span"": 45, ""end_span"": 48, ""type"": ""Gene_or_gene_product""}, {""token"": ""anti - NRP1 antibodies"", ""start_span"": 83, ""end_span"": 105, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF165"", ""start_span"": 130, ""end_span"": 137, ""type"": ""Gene_or_gene_product""}]"
Furthermore, the formation of complexes containing KDR and NRP1 markedly increased 125I - VEGF165 binding to KDR.	"KDR	51	54	Gene_or_gene_product"	"NRP1	59	63	Gene_or_gene_product"	"125I - VEGF165	83	97	Gene_or_gene_product"	"KDR	109	112	Gene_or_gene_product"	"[{""token"": ""KDR"", ""start_span"": 51, ""end_span"": 54, ""type"": ""Gene_or_gene_product""}, {""token"": ""NRP1"", ""start_span"": 59, ""end_span"": 63, ""type"": ""Gene_or_gene_product""}, {""token"": ""125I - VEGF165"", ""start_span"": 83, ""end_span"": 97, ""type"": ""Gene_or_gene_product""}, {""token"": ""KDR"", ""start_span"": 109, ""end_span"": 112, ""type"": ""Gene_or_gene_product""}]"
Most of the tumor - suppressive properties of Pten are dependent on its lipid phosphatase activity, which inhibits the phosphatidylinositol - 3 ' - kinase ( PI3K) / Akt signaling pathway through dephosphorylation of phosphatidylinositol - ( 3, 4, 5) - triphosphate.	"Pten	46	50	Gene_or_gene_product"	"phosphatidylinositol - 3 ' - kinase	119	154	Gene_or_gene_product"	"PI3K	157	161	Gene_or_gene_product"	"Akt	165	168	Gene_or_gene_product"	"[{""token"": ""Pten"", ""start_span"": 46, ""end_span"": 50, ""type"": ""Gene_or_gene_product""}, {""token"": ""phosphatidylinositol - 3 ' - kinase"", ""start_span"": 119, ""end_span"": 154, ""type"": ""Gene_or_gene_product""}, {""token"": ""PI3K"", ""start_span"": 157, ""end_span"": 161, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 165, ""end_span"": 168, ""type"": ""Gene_or_gene_product""}]"
Furthermore, the possibility of selective targeting of PTEN mutant tumor cells by specific pharmacologic inhibitors of members of the Pten / PI3K / Akt pathway opens up new perspectives for a targeted molecular therapy of malignant gliomas.	"PTEN	55	59	Gene_or_gene_product"	"Pten	134	138	Gene_or_gene_product"	"PI3K	141	145	Gene_or_gene_product"	"Akt	148	151	Gene_or_gene_product"	"[{""token"": ""PTEN"", ""start_span"": 55, ""end_span"": 59, ""type"": ""Gene_or_gene_product""}, {""token"": ""Pten"", ""start_span"": 134, ""end_span"": 138, ""type"": ""Gene_or_gene_product""}, {""token"": ""PI3K"", ""start_span"": 141, ""end_span"": 145, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 148, ""end_span"": 151, ""type"": ""Gene_or_gene_product""}]"
In the distraction group, a significant postoperative increase in MMP - 1, bFGF, ALP, and BAP could be observed during the lengthening and the consolidation period when compared with the baseline levels.	"MMP - 1	66	73	Gene_or_gene_product"	"bFGF	75	79	Gene_or_gene_product"	"ALP	81	84	Gene_or_gene_product"	"BAP	90	93	Gene_or_gene_product"	"[{""token"": ""MMP - 1"", ""start_span"": 66, ""end_span"": 73, ""type"": ""Gene_or_gene_product""}, {""token"": ""bFGF"", ""start_span"": 75, ""end_span"": 79, ""type"": ""Gene_or_gene_product""}, {""token"": ""ALP"", ""start_span"": 81, ""end_span"": 84, ""type"": ""Gene_or_gene_product""}, {""token"": ""BAP"", ""start_span"": 90, ""end_span"": 93, ""type"": ""Gene_or_gene_product""}]"
In addition, comparison of both groups revealed a significantly higher increase in TGF - beta1, IGF - I, IGFBP - 3, and hGH in the lengthening group during the distraction period, indicating key regulatory functions in mechanotransduction.	"TGF - beta1	83	94	Gene_or_gene_product"	"IGF - I	96	103	Gene_or_gene_product"	"IGFBP - 3	105	114	Gene_or_gene_product"	"hGH	120	123	Gene_or_gene_product"	"[{""token"": ""TGF - beta1"", ""start_span"": 83, ""end_span"": 94, ""type"": ""Gene_or_gene_product""}, {""token"": ""IGF - I"", ""start_span"": 96, ""end_span"": 103, ""type"": ""Gene_or_gene_product""}, {""token"": ""IGFBP - 3"", ""start_span"": 105, ""end_span"": 114, ""type"": ""Gene_or_gene_product""}, {""token"": ""hGH"", ""start_span"": 120, ""end_span"": 123, ""type"": ""Gene_or_gene_product""}]"
The time courses of changes in MMP - 1, bone growth factors ( TGF - beta1 and bFGF), and hGH, respectively, correlated significantly during the lengthening phase, indicating common regulatory pathways for these factors in distraction osteogenesis.	"MMP - 1	31	38	Gene_or_gene_product"	"TGF - beta1	62	73	Gene_or_gene_product"	"bFGF	78	82	Gene_or_gene_product"	"hGH	89	92	Gene_or_gene_product"	"[{""token"": ""MMP - 1"", ""start_span"": 31, ""end_span"": 38, ""type"": ""Gene_or_gene_product""}, {""token"": ""TGF - beta1"", ""start_span"": 62, ""end_span"": 73, ""type"": ""Gene_or_gene_product""}, {""token"": ""bFGF"", ""start_span"": 78, ""end_span"": 82, ""type"": ""Gene_or_gene_product""}, {""token"": ""hGH"", ""start_span"": 89, ""end_span"": 92, ""type"": ""Gene_or_gene_product""}]"
We identify here hADA3, human homologue of the yeast transcriptional coactivator yADA3, as a novel E6 - interacting protein and a target of E6 - induced degradation.	"hADA3	17	22	Gene_or_gene_product"	"yADA3	81	86	Gene_or_gene_product"	"E6	99	101	Gene_or_gene_product"	"E6	140	142	Gene_or_gene_product"	"[{""token"": ""hADA3"", ""start_span"": 17, ""end_span"": 22, ""type"": ""Gene_or_gene_product""}, {""token"": ""yADA3"", ""start_span"": 81, ""end_span"": 86, ""type"": ""Gene_or_gene_product""}, {""token"": ""E6"", ""start_span"": 99, ""end_span"": 101, ""type"": ""Gene_or_gene_product""}, {""token"": ""E6"", ""start_span"": 140, ""end_span"": 142, ""type"": ""Gene_or_gene_product""}]"
Blockade of PAF - R by WEB - 2170, a PAF - R antagonist, abolished the CD154 - dependent motility, indicating a role for PAF synthesized after CD154 stimulation in renal carcinoma cell motility.	"PAF - R	12	19	Gene_or_gene_product"	"PAF - R	37	44	Gene_or_gene_product"	"CD154	71	76	Gene_or_gene_product"	"CD154	143	148	Gene_or_gene_product"	"[{""token"": ""PAF - R"", ""start_span"": 12, ""end_span"": 19, ""type"": ""Gene_or_gene_product""}, {""token"": ""PAF - R"", ""start_span"": 37, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}, {""token"": ""CD154"", ""start_span"": 71, ""end_span"": 76, ""type"": ""Gene_or_gene_product""}, {""token"": ""CD154"", ""start_span"": 143, ""end_span"": 148, ""type"": ""Gene_or_gene_product""}]"
However, re - expression of wt - p53 in EU - 4 cells could restore the doxorubicin - p53 - survivin pathway, resulting in significantly decreased survivin expression and increased apoptosis in these cells after doxorubicin treatment.	"p53	33	36	Gene_or_gene_product"	"p53	85	88	Gene_or_gene_product"	"survivin	91	99	Gene_or_gene_product"	"survivin	146	154	Gene_or_gene_product"	"[{""token"": ""p53"", ""start_span"": 33, ""end_span"": 36, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 85, ""end_span"": 88, ""type"": ""Gene_or_gene_product""}, {""token"": ""survivin"", ""start_span"": 91, ""end_span"": 99, ""type"": ""Gene_or_gene_product""}, {""token"": ""survivin"", ""start_span"": 146, ""end_span"": 154, ""type"": ""Gene_or_gene_product""}]"
To assess its role on human vascular lung development, we first examined the expression of IGF - I / II and IGF receptor type I ( IGF - IR) in human embryonic and fetal lung tissues at 4 - 12 wk of gestation.	"IGF - I	91	98	Gene_or_gene_product"	"II	101	103	Gene_or_gene_product"	"IGF receptor type I	108	127	Gene_or_gene_product"	"IGF - IR	130	138	Gene_or_gene_product"	"[{""token"": ""IGF - I"", ""start_span"": 91, ""end_span"": 98, ""type"": ""Gene_or_gene_product""}, {""token"": ""II"", ""start_span"": 101, ""end_span"": 103, ""type"": ""Gene_or_gene_product""}, {""token"": ""IGF receptor type I"", ""start_span"": 108, ""end_span"": 127, ""type"": ""Gene_or_gene_product""}, {""token"": ""IGF - IR"", ""start_span"": 130, ""end_span"": 138, ""type"": ""Gene_or_gene_product""}]"
These data provide the first demonstration of IGF - I / II expression in the human lung in early gestation and indicate that the IGF family of growth factors, acting through the IGF - IR, is required as a survival factor during normal human lung vascularization.	"IGF - I	46	53	Gene_or_gene_product"	"II	56	58	Gene_or_gene_product"	"IGF	129	132	Gene_or_gene_product"	"IGF - IR	178	186	Gene_or_gene_product"	"[{""token"": ""IGF - I"", ""start_span"": 46, ""end_span"": 53, ""type"": ""Gene_or_gene_product""}, {""token"": ""II"", ""start_span"": 56, ""end_span"": 58, ""type"": ""Gene_or_gene_product""}, {""token"": ""IGF"", ""start_span"": 129, ""end_span"": 132, ""type"": ""Gene_or_gene_product""}, {""token"": ""IGF - IR"", ""start_span"": 178, ""end_span"": 186, ""type"": ""Gene_or_gene_product""}]"
HGF were stimulated with lipopolysaccharide ( LPS), vesicle ( Ve) and outer membrane protein ( OMP) from Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis.	"vesicle	52	59	Gene_or_gene_product"	"Ve	62	64	Gene_or_gene_product"	"outer membrane protein	70	92	Gene_or_gene_product"	"OMP	95	98	Gene_or_gene_product"	"[{""token"": ""vesicle"", ""start_span"": 52, ""end_span"": 59, ""type"": ""Gene_or_gene_product""}, {""token"": ""Ve"", ""start_span"": 62, ""end_span"": 64, ""type"": ""Gene_or_gene_product""}, {""token"": ""outer membrane protein"", ""start_span"": 70, ""end_span"": 92, ""type"": ""Gene_or_gene_product""}, {""token"": ""OMP"", ""start_span"": 95, ""end_span"": 98, ""type"": ""Gene_or_gene_product""}]"
Here we show that transcription of the p53 gene is induced by IFN - alpha / beta, accompanied by an increase in p53 protein level.	"p53	39	42	Gene_or_gene_product"	"IFN - alpha	62	73	Gene_or_gene_product"	"beta	76	80	Gene_or_gene_product"	"p53	112	115	Gene_or_gene_product"	"[{""token"": ""p53"", ""start_span"": 39, ""end_span"": 42, ""type"": ""Gene_or_gene_product""}, {""token"": ""IFN - alpha"", ""start_span"": 62, ""end_span"": 73, ""type"": ""Gene_or_gene_product""}, {""token"": ""beta"", ""start_span"": 76, ""end_span"": 80, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 112, ""end_span"": 115, ""type"": ""Gene_or_gene_product""}]"
IFN - alpha / beta signalling itself does not activate p53; rather, it contributes to boosting p53 responses to stress signals.	"IFN - alpha	0	11	Gene_or_gene_product"	"beta	14	18	Gene_or_gene_product"	"p53	55	58	Gene_or_gene_product"	"p53	95	98	Gene_or_gene_product"	"[{""token"": ""IFN - alpha"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Gene_or_gene_product""}, {""token"": ""beta"", ""start_span"": 14, ""end_span"": 18, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 55, ""end_span"": 58, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 95, ""end_span"": 98, ""type"": ""Gene_or_gene_product""}]"
The direct angiogenic activity of CCL16 is further amplified by its ability to prime endothelium to a mitogen signal induced by vascular endothelial growth factor A and to raise their basal production of CXCL8 and CCL2, 2 other angiogenic chemokines.	"CCL16	34	39	Gene_or_gene_product"	"vascular endothelial growth factor A	128	164	Gene_or_gene_product"	"CXCL8	204	209	Gene_or_gene_product"	"CCL2	214	218	Gene_or_gene_product"	"[{""token"": ""CCL16"", ""start_span"": 34, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""vascular endothelial growth factor A"", ""start_span"": 128, ""end_span"": 164, ""type"": ""Gene_or_gene_product""}, {""token"": ""CXCL8"", ""start_span"": 204, ""end_span"": 209, ""type"": ""Gene_or_gene_product""}, {""token"": ""CCL2"", ""start_span"": 214, ""end_span"": 218, ""type"": ""Gene_or_gene_product""}]"
Addition of the caspase inhibitor Z - VAD. fmk inhibited caspase 8 and 3 significantly but did not affect caspase 9.	"caspase	16	23	Gene_or_gene_product"	"caspase 8	57	66	Gene_or_gene_product"	"3	71	72	Gene_or_gene_product"	"caspase 9	106	115	Gene_or_gene_product"	"[{""token"": ""caspase"", ""start_span"": 16, ""end_span"": 23, ""type"": ""Gene_or_gene_product""}, {""token"": ""caspase 8"", ""start_span"": 57, ""end_span"": 66, ""type"": ""Gene_or_gene_product""}, {""token"": ""3"", ""start_span"": 71, ""end_span"": 72, ""type"": ""Gene_or_gene_product""}, {""token"": ""caspase 9"", ""start_span"": 106, ""end_span"": 115, ""type"": ""Gene_or_gene_product""}]"
Hypoxia - inducible factor 1 ( HIF - 1) activates vascular endothelial growth factor ( VEGF) gene expression in hypoxic / ischemic tissue.	"Hypoxia - inducible factor 1	0	28	Gene_or_gene_product"	"HIF - 1	31	38	Gene_or_gene_product"	"vascular endothelial growth factor	50	84	Gene_or_gene_product"	"VEGF	87	91	Gene_or_gene_product"	"[{""token"": ""Hypoxia - inducible factor 1"", ""start_span"": 0, ""end_span"": 28, ""type"": ""Gene_or_gene_product""}, {""token"": ""HIF - 1"", ""start_span"": 31, ""end_span"": 38, ""type"": ""Gene_or_gene_product""}, {""token"": ""vascular endothelial growth factor"", ""start_span"": 50, ""end_span"": 84, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 87, ""end_span"": 91, ""type"": ""Gene_or_gene_product""}]"
In epithelial cells, EphA2 and E - cadherin co - localize to sites of cell - cell contact, and it has been shown that E - cadherin regulates EphA2.	"EphA2	21	26	Gene_or_gene_product"	"E - cadherin	31	43	Gene_or_gene_product"	"E - cadherin	118	130	Gene_or_gene_product"	"EphA2	141	146	Gene_or_gene_product"	"[{""token"": ""EphA2"", ""start_span"": 21, ""end_span"": 26, ""type"": ""Gene_or_gene_product""}, {""token"": ""E - cadherin"", ""start_span"": 31, ""end_span"": 43, ""type"": ""Gene_or_gene_product""}, {""token"": ""E - cadherin"", ""start_span"": 118, ""end_span"": 130, ""type"": ""Gene_or_gene_product""}, {""token"": ""EphA2"", ""start_span"": 141, ""end_span"": 146, ""type"": ""Gene_or_gene_product""}]"
This study aimed to clarify the relationship between the expression of the EphA2 and E - cadherin proteins and clinicopathological characteristics, with reference to the expression levels of both EphA2 and E - cadherin, in patients with colorectal cancer.	"EphA2	75	80	Gene_or_gene_product"	"E - cadherin	85	97	Gene_or_gene_product"	"EphA2	196	201	Gene_or_gene_product"	"E - cadherin	206	218	Gene_or_gene_product"	"[{""token"": ""EphA2"", ""start_span"": 75, ""end_span"": 80, ""type"": ""Gene_or_gene_product""}, {""token"": ""E - cadherin"", ""start_span"": 85, ""end_span"": 97, ""type"": ""Gene_or_gene_product""}, {""token"": ""EphA2"", ""start_span"": 196, ""end_span"": 201, ""type"": ""Gene_or_gene_product""}, {""token"": ""E - cadherin"", ""start_span"": 206, ""end_span"": 218, ""type"": ""Gene_or_gene_product""}]"
We performed immunohistochemical staining of EphA2 and E - cadherin with EphA2 and E - cadherin monoclonal antibodies in samples from 194 primary lesions of colorectal cancer.	"EphA2	45	50	Gene_or_gene_product"	"E - cadherin	55	67	Gene_or_gene_product"	"EphA2	73	78	Gene_or_gene_product"	"E - cadherin	83	95	Gene_or_gene_product"	"[{""token"": ""EphA2"", ""start_span"": 45, ""end_span"": 50, ""type"": ""Gene_or_gene_product""}, {""token"": ""E - cadherin"", ""start_span"": 55, ""end_span"": 67, ""type"": ""Gene_or_gene_product""}, {""token"": ""EphA2"", ""start_span"": 73, ""end_span"": 78, ""type"": ""Gene_or_gene_product""}, {""token"": ""E - cadherin"", ""start_span"": 83, ""end_span"": 95, ""type"": ""Gene_or_gene_product""}]"
We quantified CYR61, CTGF, WISP - 1, and NOV mRNA expression levels in samples from sixty - six primary gliomas and five normal brain samples using quantitative real - time PCR assay.	"CYR61	14	19	Gene_or_gene_product"	"CTGF	21	25	Gene_or_gene_product"	"WISP - 1	27	35	Gene_or_gene_product"	"NOV	41	44	Gene_or_gene_product"	"[{""token"": ""CYR61"", ""start_span"": 14, ""end_span"": 19, ""type"": ""Gene_or_gene_product""}, {""token"": ""CTGF"", ""start_span"": 21, ""end_span"": 25, ""type"": ""Gene_or_gene_product""}, {""token"": ""WISP - 1"", ""start_span"": 27, ""end_span"": 35, ""type"": ""Gene_or_gene_product""}, {""token"": ""NOV"", ""start_span"": 41, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}]"
Overexpression of CYR61, CTGF, WISP - 1, and NOV occurred in 48% ( 32 of 66), 58% ( 38 of 66), 36% ( 24 of 66), and 15% ( 10 of 66) of primary gliomas, respectively.	"CYR61	18	23	Gene_or_gene_product"	"CTGF	25	29	Gene_or_gene_product"	"WISP - 1	31	39	Gene_or_gene_product"	"NOV	45	48	Gene_or_gene_product"	"[{""token"": ""CYR61"", ""start_span"": 18, ""end_span"": 23, ""type"": ""Gene_or_gene_product""}, {""token"": ""CTGF"", ""start_span"": 25, ""end_span"": 29, ""type"": ""Gene_or_gene_product""}, {""token"": ""WISP - 1"", ""start_span"": 31, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""NOV"", ""start_span"": 45, ""end_span"": 48, ""type"": ""Gene_or_gene_product""}]"
In contrast to CYR61 and CTGF, no significant association was found between expression of either WISP - 1 or NOV versus any of the pathological features.	"CYR61	15	20	Gene_or_gene_product"	"CTGF	25	29	Gene_or_gene_product"	"WISP - 1	97	105	Gene_or_gene_product"	"NOV	109	112	Gene_or_gene_product"	"[{""token"": ""CYR61"", ""start_span"": 15, ""end_span"": 20, ""type"": ""Gene_or_gene_product""}, {""token"": ""CTGF"", ""start_span"": 25, ""end_span"": 29, ""type"": ""Gene_or_gene_product""}, {""token"": ""WISP - 1"", ""start_span"": 97, ""end_span"": 105, ""type"": ""Gene_or_gene_product""}, {""token"": ""NOV"", ""start_span"": 109, ""end_span"": 112, ""type"": ""Gene_or_gene_product""}]"
The aim of this study is to investigate ( 1) whether expression of COX - 2 and PPARgamma is associated with ovarian carcinogenesis and progression of ovarian tumours and ( 2) whether COX - 2 expression is controlled through ligand - mediated activation of PPARgamma in ovarian carcinoma cells.	"COX - 2	67	74	Gene_or_gene_product"	"PPARgamma	79	88	Gene_or_gene_product"	"COX - 2	183	190	Gene_or_gene_product"	"PPARgamma	256	265	Gene_or_gene_product"	"[{""token"": ""COX - 2"", ""start_span"": 67, ""end_span"": 74, ""type"": ""Gene_or_gene_product""}, {""token"": ""PPARgamma"", ""start_span"": 79, ""end_span"": 88, ""type"": ""Gene_or_gene_product""}, {""token"": ""COX - 2"", ""start_span"": 183, ""end_span"": 190, ""type"": ""Gene_or_gene_product""}, {""token"": ""PPARgamma"", ""start_span"": 256, ""end_span"": 265, ""type"": ""Gene_or_gene_product""}]"
For this purpose, the presence of COX - 2 and PPARgamma was immunohistochemically examined in 71 epithelial ovarian carcinomas, 18 borderline tumours and 23 benign tumours and the levels of COX - 2 and PPARgamma proteins were determined by enzyme immunoassay in four benign tumours, three borderline tumours and 12 carcinomas.	"COX - 2	34	41	Gene_or_gene_product"	"PPARgamma	46	55	Gene_or_gene_product"	"COX - 2	190	197	Gene_or_gene_product"	"PPARgamma	202	211	Gene_or_gene_product"	"[{""token"": ""COX - 2"", ""start_span"": 34, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""PPARgamma"", ""start_span"": 46, ""end_span"": 55, ""type"": ""Gene_or_gene_product""}, {""token"": ""COX - 2"", ""start_span"": 190, ""end_span"": 197, ""type"": ""Gene_or_gene_product""}, {""token"": ""PPARgamma"", ""start_span"": 202, ""end_span"": 211, ""type"": ""Gene_or_gene_product""}]"
In addition, PPARgamma protein was not detected in all of the eight carcinomas in which COX - 2 protein was detected, suggesting that expression of PPARgamma and COX - 2 was in a reciprocal relationship.	"PPARgamma	13	22	Gene_or_gene_product"	"COX - 2	88	95	Gene_or_gene_product"	"PPARgamma	148	157	Gene_or_gene_product"	"COX - 2	162	169	Gene_or_gene_product"	"[{""token"": ""PPARgamma"", ""start_span"": 13, ""end_span"": 22, ""type"": ""Gene_or_gene_product""}, {""token"": ""COX - 2"", ""start_span"": 88, ""end_span"": 95, ""type"": ""Gene_or_gene_product""}, {""token"": ""PPARgamma"", ""start_span"": 148, ""end_span"": 157, ""type"": ""Gene_or_gene_product""}, {""token"": ""COX - 2"", ""start_span"": 162, ""end_span"": 169, ""type"": ""Gene_or_gene_product""}]"
In addition, 15d - PGJ ( 2) suppressed tumour necrosis factor - alpha - induced - COX - 2 expression, confirming the reciprocal correlation between COX - 2 and PPARgamma.	"tumour necrosis factor - alpha	39	69	Gene_or_gene_product"	"COX - 2	82	89	Gene_or_gene_product"	"COX - 2	148	155	Gene_or_gene_product"	"PPARgamma	160	169	Gene_or_gene_product"	"[{""token"": ""tumour necrosis factor - alpha"", ""start_span"": 39, ""end_span"": 69, ""type"": ""Gene_or_gene_product""}, {""token"": ""COX - 2"", ""start_span"": 82, ""end_span"": 89, ""type"": ""Gene_or_gene_product""}, {""token"": ""COX - 2"", ""start_span"": 148, ""end_span"": 155, ""type"": ""Gene_or_gene_product""}, {""token"": ""PPARgamma"", ""start_span"": 160, ""end_span"": 169, ""type"": ""Gene_or_gene_product""}]"
Glucocorticoid receptor - induced MAPK phosphatase - 1 ( MPK - 1) expression inhibits paclitaxel - associated MAPK activation and contributes to breast cancer cell survival.	"Glucocorticoid receptor	0	23	Gene_or_gene_product"	"MAPK phosphatase - 1	34	54	Gene_or_gene_product"	"MPK - 1	57	64	Gene_or_gene_product"	"MAPK	110	114	Gene_or_gene_product"	"[{""token"": ""Glucocorticoid receptor"", ""start_span"": 0, ""end_span"": 23, ""type"": ""Gene_or_gene_product""}, {""token"": ""MAPK phosphatase - 1"", ""start_span"": 34, ""end_span"": 54, ""type"": ""Gene_or_gene_product""}, {""token"": ""MPK - 1"", ""start_span"": 57, ""end_span"": 64, ""type"": ""Gene_or_gene_product""}, {""token"": ""MAPK"", ""start_span"": 110, ""end_span"": 114, ""type"": ""Gene_or_gene_product""}]"
ERK1 / 2 and JNK inactivation was associated with Ets - like transcription factor - 1 ( ELK - 1) dephosphorylation.	"ERK1 / 2	0	8	Gene_or_gene_product"	"JNK	13	16	Gene_or_gene_product"	"Ets - like transcription factor - 1	50	85	Gene_or_gene_product"	"ELK - 1	88	95	Gene_or_gene_product"	"[{""token"": ""ERK1 / 2"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Gene_or_gene_product""}, {""token"": ""JNK"", ""start_span"": 13, ""end_span"": 16, ""type"": ""Gene_or_gene_product""}, {""token"": ""Ets - like transcription factor - 1"", ""start_span"": 50, ""end_span"": 85, ""type"": ""Gene_or_gene_product""}, {""token"": ""ELK - 1"", ""start_span"": 88, ""end_span"": 95, ""type"": ""Gene_or_gene_product""}]"
These findings demonstrate a requirement for VEGFR1 + haematopoietic progenitors in the regulation of metastasis, and suggest that expression patterns of fibronectin and VEGFR1 + VLA - 4 + clusters dictate organ - specific tumour spread.	"VEGFR1	45	51	Gene_or_gene_product"	"fibronectin	154	165	Gene_or_gene_product"	"VEGFR1	170	176	Gene_or_gene_product"	"VLA - 4	179	186	Gene_or_gene_product"	"[{""token"": ""VEGFR1"", ""start_span"": 45, ""end_span"": 51, ""type"": ""Gene_or_gene_product""}, {""token"": ""fibronectin"", ""start_span"": 154, ""end_span"": 165, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGFR1"", ""start_span"": 170, ""end_span"": 176, ""type"": ""Gene_or_gene_product""}, {""token"": ""VLA - 4"", ""start_span"": 179, ""end_span"": 186, ""type"": ""Gene_or_gene_product""}]"
To this end, we generated endothelial cell lines stably expressing vGPCR or key KSHV latently expressed proteins ( vCyclin, vFlip, and LANA1).	"vGPCR	67	72	Gene_or_gene_product"	"vCyclin	115	122	Gene_or_gene_product"	"vFlip	124	129	Gene_or_gene_product"	"LANA1	135	140	Gene_or_gene_product"	"[{""token"": ""vGPCR"", ""start_span"": 67, ""end_span"": 72, ""type"": ""Gene_or_gene_product""}, {""token"": ""vCyclin"", ""start_span"": 115, ""end_span"": 122, ""type"": ""Gene_or_gene_product""}, {""token"": ""vFlip"", ""start_span"": 124, ""end_span"": 129, ""type"": ""Gene_or_gene_product""}, {""token"": ""LANA1"", ""start_span"": 135, ""end_span"": 140, ""type"": ""Gene_or_gene_product""}]"
The relative resistance of PC - 3 cells to drug - induced apoptosis was associated with constitutive Akt activation, higher levels of cFLIP - L and Bcl - 2, and lower levels of Bax.	"Akt	101	104	Gene_or_gene_product"	"cFLIP - L	134	143	Gene_or_gene_product"	"Bcl - 2	148	155	Gene_or_gene_product"	"Bax	177	180	Gene_or_gene_product"	"[{""token"": ""Akt"", ""start_span"": 101, ""end_span"": 104, ""type"": ""Gene_or_gene_product""}, {""token"": ""cFLIP - L"", ""start_span"": 134, ""end_span"": 143, ""type"": ""Gene_or_gene_product""}, {""token"": ""Bcl - 2"", ""start_span"": 148, ""end_span"": 155, ""type"": ""Gene_or_gene_product""}, {""token"": ""Bax"", ""start_span"": 177, ""end_span"": 180, ""type"": ""Gene_or_gene_product""}]"
In contrast, expression of kinase - dead PIM - 2 mutant ( PIM - 2KD) led to a rapid decline of survival in Ba / F3 cells transformed by FLT3 - ITD but not by other oncogenic PTKs tested.	"PIM - 2	41	48	Gene_or_gene_product"	"PIM - 2KD	58	67	Gene_or_gene_product"	"FLT3 - ITD	136	146	Gene_or_gene_product"	"PTKs	174	178	Gene_or_gene_product"	"[{""token"": ""PIM - 2"", ""start_span"": 41, ""end_span"": 48, ""type"": ""Gene_or_gene_product""}, {""token"": ""PIM - 2KD"", ""start_span"": 58, ""end_span"": 67, ""type"": ""Gene_or_gene_product""}, {""token"": ""FLT3 - ITD"", ""start_span"": 136, ""end_span"": 146, ""type"": ""Gene_or_gene_product""}, {""token"": ""PTKs"", ""start_span"": 174, ""end_span"": 178, ""type"": ""Gene_or_gene_product""}]"
Coexpression of PIM - 1KD and PIM - 2KD abrogated growth factor - independent growth of Ba / F3 transformed by several PTKs, including BCR / ABL.	"PIM - 1KD	16	25	Gene_or_gene_product"	"PIM - 2KD	30	39	Gene_or_gene_product"	"BCR	135	138	Gene_or_gene_product"	"ABL	141	144	Gene_or_gene_product"	"[{""token"": ""PIM - 1KD"", ""start_span"": 16, ""end_span"": 25, ""type"": ""Gene_or_gene_product""}, {""token"": ""PIM - 2KD"", ""start_span"": 30, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""BCR"", ""start_span"": 135, ""end_span"": 138, ""type"": ""Gene_or_gene_product""}, {""token"": ""ABL"", ""start_span"": 141, ""end_span"": 144, ""type"": ""Gene_or_gene_product""}]"
Targeted down - regulation of PIM - 2 by RNA interference ( RNAi) selectively abrogated survival of Ba / F3 cells transformed by various Fms - like tyrosine kinase 3 ( FLT3) - activating mutants [ internal tandem duplication ( ITD) and kinase domain] and attenuated growth of human cell lines containing FLT3 mutations.	"PIM - 2	30	37	Gene_or_gene_product"	"Fms - like tyrosine kinase 3	137	165	Gene_or_gene_product"	"FLT3	168	172	Gene_or_gene_product"	"FLT3	304	308	Gene_or_gene_product"	"[{""token"": ""PIM - 2"", ""start_span"": 30, ""end_span"": 37, ""type"": ""Gene_or_gene_product""}, {""token"": ""Fms - like tyrosine kinase 3"", ""start_span"": 137, ""end_span"": 165, ""type"": ""Gene_or_gene_product""}, {""token"": ""FLT3"", ""start_span"": 168, ""end_span"": 172, ""type"": ""Gene_or_gene_product""}, {""token"": ""FLT3"", ""start_span"": 304, ""end_span"": 308, ""type"": ""Gene_or_gene_product""}]"
Finally, the inhibition of PAK activation enhances the PSMA / filamin A interaction and, thus, boosts PSMA activity.	"PAK	27	30	Gene_or_gene_product"	"PSMA	55	59	Gene_or_gene_product"	"filamin A	62	71	Gene_or_gene_product"	"PSMA	102	106	Gene_or_gene_product"	"[{""token"": ""PAK"", ""start_span"": 27, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""PSMA"", ""start_span"": 55, ""end_span"": 59, ""type"": ""Gene_or_gene_product""}, {""token"": ""filamin A"", ""start_span"": 62, ""end_span"": 71, ""type"": ""Gene_or_gene_product""}, {""token"": ""PSMA"", ""start_span"": 102, ""end_span"": 106, ""type"": ""Gene_or_gene_product""}]"
The fibrinolytic ( plasminogen / plasmin) and matrix metalloproteinase ( MMP) systems cooperate in these processes.	"plasminogen	19	30	Gene_or_gene_product"	"plasmin	33	40	Gene_or_gene_product"	"matrix metalloproteinase	46	70	Gene_or_gene_product"	"MMP	73	76	Gene_or_gene_product"	"[{""token"": ""plasminogen"", ""start_span"": 19, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""plasmin"", ""start_span"": 33, ""end_span"": 40, ""type"": ""Gene_or_gene_product""}, {""token"": ""matrix metalloproteinase"", ""start_span"": 46, ""end_span"": 70, ""type"": ""Gene_or_gene_product""}, {""token"": ""MMP"", ""start_span"": 73, ""end_span"": 76, ""type"": ""Gene_or_gene_product""}]"
Surprisingly, analysis of K5CDK4 and K5CDK2 transgenic mouse embryos showed CDK4 and CDK2 expression not only in the expected tissues, but also in the adenohypophysis.	"K5CDK4	26	32	Gene_or_gene_product"	"K5CDK2	37	43	Gene_or_gene_product"	"CDK4	76	80	Gene_or_gene_product"	"CDK2	85	89	Gene_or_gene_product"	"[{""token"": ""K5CDK4"", ""start_span"": 26, ""end_span"": 32, ""type"": ""Gene_or_gene_product""}, {""token"": ""K5CDK2"", ""start_span"": 37, ""end_span"": 43, ""type"": ""Gene_or_gene_product""}, {""token"": ""CDK4"", ""start_span"": 76, ""end_span"": 80, ""type"": ""Gene_or_gene_product""}, {""token"": ""CDK2"", ""start_span"": 85, ""end_span"": 89, ""type"": ""Gene_or_gene_product""}]"
We assessed survivin expression in breast carcinomas correlating results with expression of other antiapoptotic ( bcl - 2, bcl - x) and proapoptotic ( bax) markers, with prognostic parameters, and with prognosis.	"survivin	12	20	Gene_or_gene_product"	"bcl - 2	114	121	Gene_or_gene_product"	"bcl - x	123	130	Gene_or_gene_product"	"bax	151	154	Gene_or_gene_product"	"[{""token"": ""survivin"", ""start_span"": 12, ""end_span"": 20, ""type"": ""Gene_or_gene_product""}, {""token"": ""bcl - 2"", ""start_span"": 114, ""end_span"": 121, ""type"": ""Gene_or_gene_product""}, {""token"": ""bcl - x"", ""start_span"": 123, ""end_span"": 130, ""type"": ""Gene_or_gene_product""}, {""token"": ""bax"", ""start_span"": 151, ""end_span"": 154, ""type"": ""Gene_or_gene_product""}]"
DESIGN: Paraffin - embedded sections of 37 breast carcinomas were immunostained for survivin, bcl - 2, bcl - x, and bax.	"survivin	84	92	Gene_or_gene_product"	"bcl - 2	94	101	Gene_or_gene_product"	"bcl - x	103	110	Gene_or_gene_product"	"bax	116	119	Gene_or_gene_product"	"[{""token"": ""survivin"", ""start_span"": 84, ""end_span"": 92, ""type"": ""Gene_or_gene_product""}, {""token"": ""bcl - 2"", ""start_span"": 94, ""end_span"": 101, ""type"": ""Gene_or_gene_product""}, {""token"": ""bcl - x"", ""start_span"": 103, ""end_span"": 110, ""type"": ""Gene_or_gene_product""}, {""token"": ""bax"", ""start_span"": 116, ""end_span"": 119, ""type"": ""Gene_or_gene_product""}]"
There was a significant correlation ( P = 0. 022) between survivin and bcl - x expression; survivin and bcl - x tended to correlate with overall survival ( P = 0. 072 and 0. 075, respectively), but not with disease - free survival ( P = 0. 19 and 0. 18, respectively).	"survivin	58	66	Gene_or_gene_product"	"bcl - x	71	78	Gene_or_gene_product"	"survivin	91	99	Gene_or_gene_product"	"bcl - x	104	111	Gene_or_gene_product"	"[{""token"": ""survivin"", ""start_span"": 58, ""end_span"": 66, ""type"": ""Gene_or_gene_product""}, {""token"": ""bcl - x"", ""start_span"": 71, ""end_span"": 78, ""type"": ""Gene_or_gene_product""}, {""token"": ""survivin"", ""start_span"": 91, ""end_span"": 99, ""type"": ""Gene_or_gene_product""}, {""token"": ""bcl - x"", ""start_span"": 104, ""end_span"": 111, ""type"": ""Gene_or_gene_product""}]"
Results show that the process: VEGF - a - - greater than EphA2 - - greater than MMPs - - greater than VM is the main pathway for VM formation and VEGF - a appears to play an important role in the formation of VM based on our in vitro assays and clinical immunohistochemical analyses.	"VEGF - a	31	39	Gene_or_gene_product"	"EphA2	57	62	Gene_or_gene_product"	"MMPs	80	84	Gene_or_gene_product"	"VEGF - a	146	154	Gene_or_gene_product"	"[{""token"": ""VEGF - a"", ""start_span"": 31, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""EphA2"", ""start_span"": 57, ""end_span"": 62, ""type"": ""Gene_or_gene_product""}, {""token"": ""MMPs"", ""start_span"": 80, ""end_span"": 84, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF - a"", ""start_span"": 146, ""end_span"": 154, ""type"": ""Gene_or_gene_product""}]"
Transforming growth factor - beta ( TGF - beta), a major factor in the activation of fibroblasts, increased alpha - SMA and desmin expression and the ability of cell migration and invasion in NIH3T3 cells.	"Transforming growth factor - beta	0	33	Gene_or_gene_product"	"TGF - beta	36	46	Gene_or_gene_product"	"alpha - SMA	108	119	Gene_or_gene_product"	"desmin	124	130	Gene_or_gene_product"	"[{""token"": ""Transforming growth factor - beta"", ""start_span"": 0, ""end_span"": 33, ""type"": ""Gene_or_gene_product""}, {""token"": ""TGF - beta"", ""start_span"": 36, ""end_span"": 46, ""type"": ""Gene_or_gene_product""}, {""token"": ""alpha - SMA"", ""start_span"": 108, ""end_span"": 119, ""type"": ""Gene_or_gene_product""}, {""token"": ""desmin"", ""start_span"": 124, ""end_span"": 130, ""type"": ""Gene_or_gene_product""}]"
Enhancement of docetaxel - induced cytotoxicity and apoptosis by all - trans retinoic acid ( ATRA) through downregulation of survivin ( BIRC5), MCL - 1 and LTbeta - R in hormone - and drug resistant prostate cancer cell line, DU - 145.	"survivin	125	133	Gene_or_gene_product"	"BIRC5	136	141	Gene_or_gene_product"	"MCL - 1	144	151	Gene_or_gene_product"	"LTbeta - R	156	166	Gene_or_gene_product"	"[{""token"": ""survivin"", ""start_span"": 125, ""end_span"": 133, ""type"": ""Gene_or_gene_product""}, {""token"": ""BIRC5"", ""start_span"": 136, ""end_span"": 141, ""type"": ""Gene_or_gene_product""}, {""token"": ""MCL - 1"", ""start_span"": 144, ""end_span"": 151, ""type"": ""Gene_or_gene_product""}, {""token"": ""LTbeta - R"", ""start_span"": 156, ""end_span"": 166, ""type"": ""Gene_or_gene_product""}]"
The activity of mitochondrial hexokinase was not inhibited by 150 microM 3 - BrPA, but this concentration caused more than 70% inhibition of GAPDH ( glyceraldehyde - 3 - phosphate dehydrogenase) and 3 - phosphoglycerate kinase activities.	"hexokinase	30	40	Gene_or_gene_product"	"GAPDH	141	146	Gene_or_gene_product"	"glyceraldehyde - 3 - phosphate dehydrogenase	149	193	Gene_or_gene_product"	"3 - phosphoglycerate kinase	199	226	Gene_or_gene_product"	"[{""token"": ""hexokinase"", ""start_span"": 30, ""end_span"": 40, ""type"": ""Gene_or_gene_product""}, {""token"": ""GAPDH"", ""start_span"": 141, ""end_span"": 146, ""type"": ""Gene_or_gene_product""}, {""token"": ""glyceraldehyde - 3 - phosphate dehydrogenase"", ""start_span"": 149, ""end_span"": 193, ""type"": ""Gene_or_gene_product""}, {""token"": ""3 - phosphoglycerate kinase"", ""start_span"": 199, ""end_span"": 226, ""type"": ""Gene_or_gene_product""}]"
In this study, we have investigated gene knockdown analysis of endothelial Robos, in particular roundabout 4 ( robo4), the predominant Robo in endothelial cells using small interfering RNA technology in vitro.	"Robos	75	80	Gene_or_gene_product"	"roundabout 4	96	108	Gene_or_gene_product"	"robo4	111	116	Gene_or_gene_product"	"Robo	135	139	Gene_or_gene_product"	"[{""token"": ""Robos"", ""start_span"": 75, ""end_span"": 80, ""type"": ""Gene_or_gene_product""}, {""token"": ""roundabout 4"", ""start_span"": 96, ""end_span"": 108, ""type"": ""Gene_or_gene_product""}, {""token"": ""robo4"", ""start_span"": 111, ""end_span"": 116, ""type"": ""Gene_or_gene_product""}, {""token"": ""Robo"", ""start_span"": 135, ""end_span"": 139, ""type"": ""Gene_or_gene_product""}]"
The knockdown of robo4 abrogated the chemotactic response of endothelial cells to serum but enhanced a chemokinetic response to Slit2, while robo1 knockdown cells do not display chemotactic response to serum or VEGF.	"robo4	17	22	Gene_or_gene_product"	"Slit2	128	133	Gene_or_gene_product"	"robo1	141	146	Gene_or_gene_product"	"VEGF	211	215	Gene_or_gene_product"	"[{""token"": ""robo4"", ""start_span"": 17, ""end_span"": 22, ""type"": ""Gene_or_gene_product""}, {""token"": ""Slit2"", ""start_span"": 128, ""end_span"": 133, ""type"": ""Gene_or_gene_product""}, {""token"": ""robo1"", ""start_span"": 141, ""end_span"": 146, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 211, ""end_span"": 215, ""type"": ""Gene_or_gene_product""}]"
In addition, this study mechanistically implicates IRSp53 in the signaling nexus between activated Cdc42 and Mena, both of which have previously been shown to be involved with Robo4 signaling in endothelial cells.	"IRSp53	51	57	Gene_or_gene_product"	"Cdc42	99	104	Gene_or_gene_product"	"Mena	109	113	Gene_or_gene_product"	"Robo4	176	181	Gene_or_gene_product"	"[{""token"": ""IRSp53"", ""start_span"": 51, ""end_span"": 57, ""type"": ""Gene_or_gene_product""}, {""token"": ""Cdc42"", ""start_span"": 99, ""end_span"": 104, ""type"": ""Gene_or_gene_product""}, {""token"": ""Mena"", ""start_span"": 109, ""end_span"": 113, ""type"": ""Gene_or_gene_product""}, {""token"": ""Robo4"", ""start_span"": 176, ""end_span"": 181, ""type"": ""Gene_or_gene_product""}]"
In the present study, we performed a series of molecular imaging experiments using a HIF - 1 - dependent reporter gene, 5HREp - ODD - luc, and found an essential role of the Akt / mTOR pathway.	"HIF - 1	85	92	Gene_or_gene_product"	"5HREp - ODD - luc	120	137	Gene_or_gene_product"	"Akt	174	177	Gene_or_gene_product"	"mTOR	180	184	Gene_or_gene_product"	"[{""token"": ""HIF - 1"", ""start_span"": 85, ""end_span"": 92, ""type"": ""Gene_or_gene_product""}, {""token"": ""5HREp - ODD - luc"", ""start_span"": 120, ""end_span"": 137, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 174, ""end_span"": 177, ""type"": ""Gene_or_gene_product""}, {""token"": ""mTOR"", ""start_span"": 180, ""end_span"": 184, ""type"": ""Gene_or_gene_product""}]"
All of these results indicate that Akt / mTOR - dependent translation of HIF - 1alpha plays a critical role in the postirradiation up - regulation of intratumoral HIF - 1 activity in response to radiation - induced alterations of glucose and oxygen availability in a solid tumor.	"Akt	35	38	Gene_or_gene_product"	"mTOR	41	45	Gene_or_gene_product"	"HIF - 1alpha	73	85	Gene_or_gene_product"	"HIF - 1	163	170	Gene_or_gene_product"	"[{""token"": ""Akt"", ""start_span"": 35, ""end_span"": 38, ""type"": ""Gene_or_gene_product""}, {""token"": ""mTOR"", ""start_span"": 41, ""end_span"": 45, ""type"": ""Gene_or_gene_product""}, {""token"": ""HIF - 1alpha"", ""start_span"": 73, ""end_span"": 85, ""type"": ""Gene_or_gene_product""}, {""token"": ""HIF - 1"", ""start_span"": 163, ""end_span"": 170, ""type"": ""Gene_or_gene_product""}]"
SDF - 1alpha induced rapid phosphorylation of Erk1 / 2 MAPK but did not promote phosphorylation of Stat3 or Akt.	"SDF - 1alpha	0	12	Gene_or_gene_product"	"Erk1 / 2 MAPK	46	59	Gene_or_gene_product"	"Stat3	99	104	Gene_or_gene_product"	"Akt	108	111	Gene_or_gene_product"	"[{""token"": ""SDF - 1alpha"", ""start_span"": 0, ""end_span"": 12, ""type"": ""Gene_or_gene_product""}, {""token"": ""Erk1 / 2 MAPK"", ""start_span"": 46, ""end_span"": 59, ""type"": ""Gene_or_gene_product""}, {""token"": ""Stat3"", ""start_span"": 99, ""end_span"": 104, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 108, ""end_span"": 111, ""type"": ""Gene_or_gene_product""}]"
Western blotting analysis showed that liposomal honokiol - inhibited Akt and MAPK phosphorylation in 2 endothelial cells, and downregulated expressions of VEGFR - 2 of human vascular endothelial cells and VEGFR - 3 of lymphatic endothelial cells.	"Akt	69	72	Gene_or_gene_product"	"MAPK	77	81	Gene_or_gene_product"	"VEGFR - 2	155	164	Gene_or_gene_product"	"VEGFR - 3	205	214	Gene_or_gene_product"	"[{""token"": ""Akt"", ""start_span"": 69, ""end_span"": 72, ""type"": ""Gene_or_gene_product""}, {""token"": ""MAPK"", ""start_span"": 77, ""end_span"": 81, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGFR - 2"", ""start_span"": 155, ""end_span"": 164, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGFR - 3"", ""start_span"": 205, ""end_span"": 214, ""type"": ""Gene_or_gene_product""}]"
RESULTS: P14 and P18 blocked endothelial cell chemotaxis; P18 and P23 induced apoptosis.	"P14	9	12	Gene_or_gene_product"	"P18	17	20	Gene_or_gene_product"	"P18	58	61	Gene_or_gene_product"	"P23	66	69	Gene_or_gene_product"	"[{""token"": ""P14"", ""start_span"": 9, ""end_span"": 12, ""type"": ""Gene_or_gene_product""}, {""token"": ""P18"", ""start_span"": 17, ""end_span"": 20, ""type"": ""Gene_or_gene_product""}, {""token"": ""P18"", ""start_span"": 58, ""end_span"": 61, ""type"": ""Gene_or_gene_product""}, {""token"": ""P23"", ""start_span"": 66, ""end_span"": 69, ""type"": ""Gene_or_gene_product""}]"
Typically, proliferation and chemotaxis of endothelial cells is driven by growth factors such as vascular endothelial growth factor ( VEGF) and basic fibroblast growth factor ( bFGF).	"vascular endothelial growth factor	97	131	Gene_or_gene_product"	"VEGF	134	138	Gene_or_gene_product"	"basic fibroblast growth factor	144	174	Gene_or_gene_product"	"bFGF	177	181	Gene_or_gene_product"	"[{""token"": ""vascular endothelial growth factor"", ""start_span"": 97, ""end_span"": 131, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 134, ""end_span"": 138, ""type"": ""Gene_or_gene_product""}, {""token"": ""basic fibroblast growth factor"", ""start_span"": 144, ""end_span"": 174, ""type"": ""Gene_or_gene_product""}, {""token"": ""bFGF"", ""start_span"": 177, ""end_span"": 181, ""type"": ""Gene_or_gene_product""}]"
VEGF activates phospholipases ( PLCs) - specifically PLCgamma1 - that are important for tubulogenesis, differentiation and DNA synthesis.	"VEGF	0	4	Gene_or_gene_product"	"phospholipases	15	29	Gene_or_gene_product"	"PLCs	32	36	Gene_or_gene_product"	"PLCgamma1	53	62	Gene_or_gene_product"	"[{""token"": ""VEGF"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene_or_gene_product""}, {""token"": ""phospholipases"", ""start_span"": 15, ""end_span"": 29, ""type"": ""Gene_or_gene_product""}, {""token"": ""PLCs"", ""start_span"": 32, ""end_span"": 36, ""type"": ""Gene_or_gene_product""}, {""token"": ""PLCgamma1"", ""start_span"": 53, ""end_span"": 62, ""type"": ""Gene_or_gene_product""}]"
Given that PLCbeta3 is typically known as an effector of heterotrimeric G - proteins, our data demonstrate a unique crosstalk between the G - protein and receptor tyrosine kinase ( RTK) axes and reveal a novel molecular mechanism of VEGF signaling and, thus, angiogenesis.	"PLCbeta3	11	19	Gene_or_gene_product"	"heterotrimeric G - proteins	57	84	Gene_or_gene_product"	"G - protein	138	149	Gene_or_gene_product"	"VEGF	233	237	Gene_or_gene_product"	"[{""token"": ""PLCbeta3"", ""start_span"": 11, ""end_span"": 19, ""type"": ""Gene_or_gene_product""}, {""token"": ""heterotrimeric G - proteins"", ""start_span"": 57, ""end_span"": 84, ""type"": ""Gene_or_gene_product""}, {""token"": ""G - protein"", ""start_span"": 138, ""end_span"": 149, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 233, ""end_span"": 237, ""type"": ""Gene_or_gene_product""}]"
Exposure of wild - type primary mouse cerebral endothelial cells to the CD47 ligand thrombospondin 1 ( TSP - 1) induced an increasing amount of cell death, whereas cytotoxicity was significantly decreased in cerebral endothelial cells derived from CD47 knockout mice.	"CD47	72	76	Gene_or_gene_product"	"thrombospondin 1	84	100	Gene_or_gene_product"	"TSP - 1	103	110	Gene_or_gene_product"	"CD47	248	252	Gene_or_gene_product"	"[{""token"": ""CD47"", ""start_span"": 72, ""end_span"": 76, ""type"": ""Gene_or_gene_product""}, {""token"": ""thrombospondin 1"", ""start_span"": 84, ""end_span"": 100, ""type"": ""Gene_or_gene_product""}, {""token"": ""TSP - 1"", ""start_span"": 103, ""end_span"": 110, ""type"": ""Gene_or_gene_product""}, {""token"": ""CD47"", ""start_span"": 248, ""end_span"": 252, ""type"": ""Gene_or_gene_product""}]"
In addition, cisplatin markedly reduced MMP2 activity in both conditioned media and cell lysates, increased p38 MAPK and JNK phosphorylation, but did not affect ERK phosphorylation.	"MMP2	40	44	Gene_or_gene_product"	"p38 MAPK	108	116	Gene_or_gene_product"	"JNK	121	124	Gene_or_gene_product"	"ERK	161	164	Gene_or_gene_product"	"[{""token"": ""MMP2"", ""start_span"": 40, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}, {""token"": ""p38 MAPK"", ""start_span"": 108, ""end_span"": 116, ""type"": ""Gene_or_gene_product""}, {""token"": ""JNK"", ""start_span"": 121, ""end_span"": 124, ""type"": ""Gene_or_gene_product""}, {""token"": ""ERK"", ""start_span"": 161, ""end_span"": 164, ""type"": ""Gene_or_gene_product""}]"
Perlecan was also found to stimulate endothelial cell proliferation in vitro over a period of 6 days in the presence of plasma proteins and fibroblastic growth factor 2 ( FGF - 2), however in the absence of FGF - 2 endothelial cell growth could not be maintained during this period.	"Perlecan	0	8	Gene_or_gene_product"	"fibroblastic growth factor 2	140	168	Gene_or_gene_product"	"FGF - 2	171	178	Gene_or_gene_product"	"FGF - 2	207	214	Gene_or_gene_product"	"[{""token"": ""Perlecan"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Gene_or_gene_product""}, {""token"": ""fibroblastic growth factor 2"", ""start_span"": 140, ""end_span"": 168, ""type"": ""Gene_or_gene_product""}, {""token"": ""FGF - 2"", ""start_span"": 171, ""end_span"": 178, ""type"": ""Gene_or_gene_product""}, {""token"": ""FGF - 2"", ""start_span"": 207, ""end_span"": 214, ""type"": ""Gene_or_gene_product""}]"
Antiprogestin RU - 486 inhibits the induction of VEGF and TSP - 1 by progestins, suggesting that this effect of progestin is mediated by the progesterone receptor ( PR).	"VEGF	49	53	Gene_or_gene_product"	"TSP - 1	58	65	Gene_or_gene_product"	"progesterone receptor	141	162	Gene_or_gene_product"	"PR	165	167	Gene_or_gene_product"	"[{""token"": ""VEGF"", ""start_span"": 49, ""end_span"": 53, ""type"": ""Gene_or_gene_product""}, {""token"": ""TSP - 1"", ""start_span"": 58, ""end_span"": 65, ""type"": ""Gene_or_gene_product""}, {""token"": ""progesterone receptor"", ""start_span"": 141, ""end_span"": 162, ""type"": ""Gene_or_gene_product""}, {""token"": ""PR"", ""start_span"": 165, ""end_span"": 167, ""type"": ""Gene_or_gene_product""}]"
WNT / TCF signaling through LEF1 and HOXB9 mediates lung adenocarcinoma metastasis.	"WNT	0	3	Gene_or_gene_product"	"TCF	6	9	Gene_or_gene_product"	"LEF1	28	32	Gene_or_gene_product"	"HOXB9	37	42	Gene_or_gene_product"	"[{""token"": ""WNT"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene_or_gene_product""}, {""token"": ""TCF"", ""start_span"": 6, ""end_span"": 9, ""type"": ""Gene_or_gene_product""}, {""token"": ""LEF1"", ""start_span"": 28, ""end_span"": 32, ""type"": ""Gene_or_gene_product""}, {""token"": ""HOXB9"", ""start_span"": 37, ""end_span"": 42, ""type"": ""Gene_or_gene_product""}]"
The WNT / TCF target genes HOXB9 and LEF1 are identified as mediators of chemotactic invasion and colony outgrowth.	"WNT	4	7	Gene_or_gene_product"	"TCF	10	13	Gene_or_gene_product"	"HOXB9	27	32	Gene_or_gene_product"	"LEF1	37	41	Gene_or_gene_product"	"[{""token"": ""WNT"", ""start_span"": 4, ""end_span"": 7, ""type"": ""Gene_or_gene_product""}, {""token"": ""TCF"", ""start_span"": 10, ""end_span"": 13, ""type"": ""Gene_or_gene_product""}, {""token"": ""HOXB9"", ""start_span"": 27, ""end_span"": 32, ""type"": ""Gene_or_gene_product""}, {""token"": ""LEF1"", ""start_span"": 37, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}]"
Thus, a distinct WNT / TCF signaling program through LEF1 and HOXB9 enhances the competence of lung adenocarcinoma cells to colonize the bones and the brain.	"WNT	17	20	Gene_or_gene_product"	"TCF	23	26	Gene_or_gene_product"	"LEF1	53	57	Gene_or_gene_product"	"HOXB9	62	67	Gene_or_gene_product"	"[{""token"": ""WNT"", ""start_span"": 17, ""end_span"": 20, ""type"": ""Gene_or_gene_product""}, {""token"": ""TCF"", ""start_span"": 23, ""end_span"": 26, ""type"": ""Gene_or_gene_product""}, {""token"": ""LEF1"", ""start_span"": 53, ""end_span"": 57, ""type"": ""Gene_or_gene_product""}, {""token"": ""HOXB9"", ""start_span"": 62, ""end_span"": 67, ""type"": ""Gene_or_gene_product""}]"
Vascular endothelial growth factor ( VEGF), fibroblast growth factor ( FGF), recombinant proteins and bone marrow stem cells are currently used therapeutic stimulators for angiogenesis.	"Vascular endothelial growth factor	0	34	Gene_or_gene_product"	"VEGF	37	41	Gene_or_gene_product"	"fibroblast growth factor	44	68	Gene_or_gene_product"	"FGF	71	74	Gene_or_gene_product"	"[{""token"": ""Vascular endothelial growth factor"", ""start_span"": 0, ""end_span"": 34, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 37, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""fibroblast growth factor"", ""start_span"": 44, ""end_span"": 68, ""type"": ""Gene_or_gene_product""}, {""token"": ""FGF"", ""start_span"": 71, ""end_span"": 74, ""type"": ""Gene_or_gene_product""}]"
Using a human recombinant antibody ( scFv) specific for the angiogenesis marker domain B of fibronectin, interleukin 2, and an scFv able to neutralize tumor necrosis factor - alpha, we expressed various biologically active uteroglobin fusion proteins.	"fibronectin	92	103	Gene_or_gene_product"	"interleukin 2	105	118	Gene_or_gene_product"	"tumor necrosis factor - alpha	151	180	Gene_or_gene_product"	"uteroglobin	223	234	Gene_or_gene_product"	"[{""token"": ""fibronectin"", ""start_span"": 92, ""end_span"": 103, ""type"": ""Gene_or_gene_product""}, {""token"": ""interleukin 2"", ""start_span"": 105, ""end_span"": 118, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor necrosis factor - alpha"", ""start_span"": 151, ""end_span"": 180, ""type"": ""Gene_or_gene_product""}, {""token"": ""uteroglobin"", ""start_span"": 223, ""end_span"": 234, ""type"": ""Gene_or_gene_product""}]"
We previously characterized a secreted fibroblast growth factor - binding protein ( FGF - BP) as a chaperone molecule, which binds to various FGFs, enhances FGF - mediated biochemical and biologic events and importantly is a crucial rate - limiting factor for tumor - dependent angiogenesis.	"fibroblast growth factor - binding protein	39	81	Gene_or_gene_product"	"FGF - BP	84	92	Gene_or_gene_product"	"FGFs	142	146	Gene_or_gene_product"	"FGF	157	160	Gene_or_gene_product"	"[{""token"": ""fibroblast growth factor - binding protein"", ""start_span"": 39, ""end_span"": 81, ""type"": ""Gene_or_gene_product""}, {""token"": ""FGF - BP"", ""start_span"": 84, ""end_span"": 92, ""type"": ""Gene_or_gene_product""}, {""token"": ""FGFs"", ""start_span"": 142, ""end_span"": 146, ""type"": ""Gene_or_gene_product""}, {""token"": ""FGF"", ""start_span"": 157, ""end_span"": 160, ""type"": ""Gene_or_gene_product""}]"
CONCLUSION: Our results strongly support a role for PI3K / Akt / mTOR pathway in PET, which ties in with the fact that mTOR inhibitors have reached phase III trials in neuroendocrine tumors.	"PI3K	52	56	Gene_or_gene_product"	"Akt	59	62	Gene_or_gene_product"	"mTOR	65	69	Gene_or_gene_product"	"mTOR	119	123	Gene_or_gene_product"	"[{""token"": ""PI3K"", ""start_span"": 52, ""end_span"": 56, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 59, ""end_span"": 62, ""type"": ""Gene_or_gene_product""}, {""token"": ""mTOR"", ""start_span"": 65, ""end_span"": 69, ""type"": ""Gene_or_gene_product""}, {""token"": ""mTOR"", ""start_span"": 119, ""end_span"": 123, ""type"": ""Gene_or_gene_product""}]"
Blockage of the Akt pathway attenuated CREB activation, and a decrease in CREB expression reduced cellular migration / invasion and activity of MMPs.	"Akt	16	19	Gene_or_gene_product"	"CREB	39	43	Gene_or_gene_product"	"CREB	74	78	Gene_or_gene_product"	"MMPs	144	148	Gene_or_gene_product"	"[{""token"": ""Akt"", ""start_span"": 16, ""end_span"": 19, ""type"": ""Gene_or_gene_product""}, {""token"": ""CREB"", ""start_span"": 39, ""end_span"": 43, ""type"": ""Gene_or_gene_product""}, {""token"": ""CREB"", ""start_span"": 74, ""end_span"": 78, ""type"": ""Gene_or_gene_product""}, {""token"": ""MMPs"", ""start_span"": 144, ""end_span"": 148, ""type"": ""Gene_or_gene_product""}]"
Knocking down p24delta1 in insulinoma cell lines, which also resulted in the concomitant knock - down of other family members, impaired glucose - stimulated insulin secretion, decreased total cellular insulin content and reduced proinsulin biosynthesis.	"p24delta1	14	23	Gene_or_gene_product"	"insulin	27	34	Gene_or_gene_product"	"insulin	157	164	Gene_or_gene_product"	"proinsulin	229	239	Gene_or_gene_product"	"[{""token"": ""p24delta1"", ""start_span"": 14, ""end_span"": 23, ""type"": ""Gene_or_gene_product""}, {""token"": ""insulin"", ""start_span"": 27, ""end_span"": 34, ""type"": ""Gene_or_gene_product""}, {""token"": ""insulin"", ""start_span"": 157, ""end_span"": 164, ""type"": ""Gene_or_gene_product""}, {""token"": ""proinsulin"", ""start_span"": 229, ""end_span"": 239, ""type"": ""Gene_or_gene_product""}]"
Furthermore, overexpression of TLX in Ink4a / Arf ( - / -) astrocytes inhibited cell migration and invasion and promoted neurosphere formation and Nestin expression, which are hallmark characteristics of glioma stem cells, under stem cell culture conditions.	"TLX	31	34	Gene_or_gene_product"	"Ink4a	38	43	Gene_or_gene_product"	"Arf	46	49	Gene_or_gene_product"	"Nestin	147	153	Gene_or_gene_product"	"[{""token"": ""TLX"", ""start_span"": 31, ""end_span"": 34, ""type"": ""Gene_or_gene_product""}, {""token"": ""Ink4a"", ""start_span"": 38, ""end_span"": 43, ""type"": ""Gene_or_gene_product""}, {""token"": ""Arf"", ""start_span"": 46, ""end_span"": 49, ""type"": ""Gene_or_gene_product""}, {""token"": ""Nestin"", ""start_span"": 147, ""end_span"": 153, ""type"": ""Gene_or_gene_product""}]"
In accord with our hypothesis, in a variety of different FH - deficient tissues, including a novel murine model of Fh1 - deficient smooth muscle, we show a striking and progressive upregulation of a tumorigenic metabolic profile, as manifested by increased PKM2 and LDHA protein.	"FH	57	59	Gene_or_gene_product"	"Fh1	115	118	Gene_or_gene_product"	"PKM2	257	261	Gene_or_gene_product"	"LDHA	266	270	Gene_or_gene_product"	"[{""token"": ""FH"", ""start_span"": 57, ""end_span"": 59, ""type"": ""Gene_or_gene_product""}, {""token"": ""Fh1"", ""start_span"": 115, ""end_span"": 118, ""type"": ""Gene_or_gene_product""}, {""token"": ""PKM2"", ""start_span"": 257, ""end_span"": 261, ""type"": ""Gene_or_gene_product""}, {""token"": ""LDHA"", ""start_span"": 266, ""end_span"": 270, ""type"": ""Gene_or_gene_product""}]"
The construction of animals doubly mutant for brca2 and the apoptotic gene tp53 ( p53) rescued brca2 - dependent sex reversal.	"brca2	46	51	Gene_or_gene_product"	"tp53	75	79	Gene_or_gene_product"	"p53	82	85	Gene_or_gene_product"	"brca2	95	100	Gene_or_gene_product"	"[{""token"": ""brca2"", ""start_span"": 46, ""end_span"": 51, ""type"": ""Gene_or_gene_product""}, {""token"": ""tp53"", ""start_span"": 75, ""end_span"": 79, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 82, ""end_span"": 85, ""type"": ""Gene_or_gene_product""}, {""token"": ""brca2"", ""start_span"": 95, ""end_span"": 100, ""type"": ""Gene_or_gene_product""}]"
Multikinase inhibitor sorafenib inhibits proliferation and angiogenesis of tumors by suppressing the Raf / MEK / ERK signaling pathway and VEGF receptor tyrosine kinase.	"Raf	101	104	Gene_or_gene_product"	"MEK	107	110	Gene_or_gene_product"	"ERK	113	116	Gene_or_gene_product"	"VEGF receptor	139	152	Gene_or_gene_product"	"[{""token"": ""Raf"", ""start_span"": 101, ""end_span"": 104, ""type"": ""Gene_or_gene_product""}, {""token"": ""MEK"", ""start_span"": 107, ""end_span"": 110, ""type"": ""Gene_or_gene_product""}, {""token"": ""ERK"", ""start_span"": 113, ""end_span"": 116, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF receptor"", ""start_span"": 139, ""end_span"": 152, ""type"": ""Gene_or_gene_product""}]"
Both B and T lymphocytes diversify their antigen receptors through RAG1 / 2 mediated recombination, but B cells undergo two additional processes - - somatic hypermutation ( SHM) and class - switch recombination ( CSR), both initiated by activation - induced cytidine deaminase ( AID).	"RAG1	67	71	Gene_or_gene_product"	"2	74	75	Gene_or_gene_product"	"activation - induced cytidine deaminase	237	276	Gene_or_gene_product"	"AID	279	282	Gene_or_gene_product"	"[{""token"": ""RAG1"", ""start_span"": 67, ""end_span"": 71, ""type"": ""Gene_or_gene_product""}, {""token"": ""2"", ""start_span"": 74, ""end_span"": 75, ""type"": ""Gene_or_gene_product""}, {""token"": ""activation - induced cytidine deaminase"", ""start_span"": 237, ""end_span"": 276, ""type"": ""Gene_or_gene_product""}, {""token"": ""AID"", ""start_span"": 279, ""end_span"": 282, ""type"": ""Gene_or_gene_product""}]"
Although AID activity is focused at Immunoglobulin ( Ig) gene loci, it also targets a wide array of non - Ig genes including oncogenes associated with lymphomas.	"AID	9	12	Gene_or_gene_product"	"Immunoglobulin	36	50	Gene_or_gene_product"	"Ig	53	55	Gene_or_gene_product"	"Ig	106	108	Gene_or_gene_product"	"[{""token"": ""AID"", ""start_span"": 9, ""end_span"": 12, ""type"": ""Gene_or_gene_product""}, {""token"": ""Immunoglobulin"", ""start_span"": 36, ""end_span"": 50, ""type"": ""Gene_or_gene_product""}, {""token"": ""Ig"", ""start_span"": 53, ""end_span"": 55, ""type"": ""Gene_or_gene_product""}, {""token"": ""Ig"", ""start_span"": 106, ""end_span"": 108, ""type"": ""Gene_or_gene_product""}]"
Other enzymes, in anaerobic and aerobic glycolysis, which were blocked include hexokinase, phosphofructokinase, succinic and alpha - ketoglutarate dehydrogenases, as well as States 3 and 4 of oxidative phosphorylation.	"hexokinase	79	89	Gene_or_gene_product"	"phosphofructokinase	91	110	Gene_or_gene_product"	"succinic	112	120	Gene_or_gene_product"	"alpha - ketoglutarate dehydrogenases	125	161	Gene_or_gene_product"	"[{""token"": ""hexokinase"", ""start_span"": 79, ""end_span"": 89, ""type"": ""Gene_or_gene_product""}, {""token"": ""phosphofructokinase"", ""start_span"": 91, ""end_span"": 110, ""type"": ""Gene_or_gene_product""}, {""token"": ""succinic"", ""start_span"": 112, ""end_span"": 120, ""type"": ""Gene_or_gene_product""}, {""token"": ""alpha - ketoglutarate dehydrogenases"", ""start_span"": 125, ""end_span"": 161, ""type"": ""Gene_or_gene_product""}]"
The E - cadherin / alpha -, beta -, gamma - catenin complex has an invasion - suppressor function as evidenced by transfections either with sense cDNA encoding these molecules or with antisense cDNA inhibiting their expression.	"E - cadherin	4	16	Gene_or_gene_product"	"alpha -	19	26	Gene_or_gene_product"	"beta -	28	34	Gene_or_gene_product"	"gamma - catenin	36	51	Gene_or_gene_product"	"[{""token"": ""E - cadherin"", ""start_span"": 4, ""end_span"": 16, ""type"": ""Gene_or_gene_product""}, {""token"": ""alpha -"", ""start_span"": 19, ""end_span"": 26, ""type"": ""Gene_or_gene_product""}, {""token"": ""beta -"", ""start_span"": 28, ""end_span"": 34, ""type"": ""Gene_or_gene_product""}, {""token"": ""gamma - catenin"", ""start_span"": 36, ""end_span"": 51, ""type"": ""Gene_or_gene_product""}]"
Murine leukemia L1210 cells rendered deficient in glutathione peroxidase ( GPX) and phospholipid hydroperoxide glutathione peroxidase ( PHGPX) by Se deprivation ( L. Se ( -) cells) were found to be more sensitive to tert - butyl hydroperoxide ( t - BuOOH) cytotoxicity than Se - replete controls ( L. Se ( +) cells).	"glutathione peroxidase	50	72	Gene_or_gene_product"	"GPX	75	78	Gene_or_gene_product"	"phospholipid hydroperoxide glutathione peroxidase	84	133	Gene_or_gene_product"	"PHGPX	136	141	Gene_or_gene_product"	"[{""token"": ""glutathione peroxidase"", ""start_span"": 50, ""end_span"": 72, ""type"": ""Gene_or_gene_product""}, {""token"": ""GPX"", ""start_span"": 75, ""end_span"": 78, ""type"": ""Gene_or_gene_product""}, {""token"": ""phospholipid hydroperoxide glutathione peroxidase"", ""start_span"": 84, ""end_span"": 133, ""type"": ""Gene_or_gene_product""}, {""token"": ""PHGPX"", ""start_span"": 136, ""end_span"": 141, ""type"": ""Gene_or_gene_product""}]"
The putative metastasis suppressor genes, NME1 ( nm23 - 1) and NME2 ( nm23 - 2), were examined in a model system we developed to approximate the dissemination of melanoma from a primary skin tumor.	"NME1	42	46	Gene_or_gene_product"	"nm23 - 1	49	57	Gene_or_gene_product"	"NME2	63	67	Gene_or_gene_product"	"nm23 - 2	70	78	Gene_or_gene_product"	"[{""token"": ""NME1"", ""start_span"": 42, ""end_span"": 46, ""type"": ""Gene_or_gene_product""}, {""token"": ""nm23 - 1"", ""start_span"": 49, ""end_span"": 57, ""type"": ""Gene_or_gene_product""}, {""token"": ""NME2"", ""start_span"": 63, ""end_span"": 67, ""type"": ""Gene_or_gene_product""}, {""token"": ""nm23 - 2"", ""start_span"": 70, ""end_span"": 78, ""type"": ""Gene_or_gene_product""}]"
The high - oncogenic - risk HPV types associated with invasive cervical cancer produce two oncoproteins, designated E6 and E7, which interact with endogenous cell cycle regulatory proteins, including p53 and Rb.	"E6	116	118	Gene_or_gene_product"	"E7	123	125	Gene_or_gene_product"	"p53	200	203	Gene_or_gene_product"	"Rb	208	210	Gene_or_gene_product"	"[{""token"": ""E6"", ""start_span"": 116, ""end_span"": 118, ""type"": ""Gene_or_gene_product""}, {""token"": ""E7"", ""start_span"": 123, ""end_span"": 125, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 200, ""end_span"": 203, ""type"": ""Gene_or_gene_product""}, {""token"": ""Rb"", ""start_span"": 208, ""end_span"": 210, ""type"": ""Gene_or_gene_product""}]"
Anti - Fas treatment resulted in decreased p53 protein levels, while bcl - 2 and bax protein levels remained unaffected.	"Fas	7	10	Gene_or_gene_product"	"p53	43	46	Gene_or_gene_product"	"bcl - 2	69	76	Gene_or_gene_product"	"bax	81	84	Gene_or_gene_product"	"[{""token"": ""Fas"", ""start_span"": 7, ""end_span"": 10, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 43, ""end_span"": 46, ""type"": ""Gene_or_gene_product""}, {""token"": ""bcl - 2"", ""start_span"": 69, ""end_span"": 76, ""type"": ""Gene_or_gene_product""}, {""token"": ""bax"", ""start_span"": 81, ""end_span"": 84, ""type"": ""Gene_or_gene_product""}]"
Inhibition of MAP kinase kinase ( MEK) during this sustained alphavbeta3 - dependent ERK signal blocked the formation of new blood vessels while not influencing preexisting blood vessels on the CAM.	"MAP kinase kinase	14	31	Gene_or_gene_product"	"MEK	34	37	Gene_or_gene_product"	"alphavbeta3	61	72	Gene_or_gene_product"	"ERK	85	88	Gene_or_gene_product"	"[{""token"": ""MAP kinase kinase"", ""start_span"": 14, ""end_span"": 31, ""type"": ""Gene_or_gene_product""}, {""token"": ""MEK"", ""start_span"": 34, ""end_span"": 37, ""type"": ""Gene_or_gene_product""}, {""token"": ""alphavbeta3"", ""start_span"": 61, ""end_span"": 72, ""type"": ""Gene_or_gene_product""}, {""token"": ""ERK"", ""start_span"": 85, ""end_span"": 88, ""type"": ""Gene_or_gene_product""}]"
The E2F - 1 protein is able to induce generalized apoptosis in gliomas independently of the p53, p16 or Rb status.	"E2F - 1	4	11	Gene_or_gene_product"	"p53	92	95	Gene_or_gene_product"	"p16	97	100	Gene_or_gene_product"	"Rb	104	106	Gene_or_gene_product"	"[{""token"": ""E2F - 1"", ""start_span"": 4, ""end_span"": 11, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 92, ""end_span"": 95, ""type"": ""Gene_or_gene_product""}, {""token"": ""p16"", ""start_span"": 97, ""end_span"": 100, ""type"": ""Gene_or_gene_product""}, {""token"": ""Rb"", ""start_span"": 104, ""end_span"": 106, ""type"": ""Gene_or_gene_product""}]"
The apoptotic molecule bax is induced in p53 - mediated apoptosis, but bax is not induced in E2F - 1 - mediated apoptosis in glioma cells.	"bax	23	26	Gene_or_gene_product"	"p53	41	44	Gene_or_gene_product"	"bax	71	74	Gene_or_gene_product"	"E2F - 1	93	100	Gene_or_gene_product"	"[{""token"": ""bax"", ""start_span"": 23, ""end_span"": 26, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 41, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}, {""token"": ""bax"", ""start_span"": 71, ""end_span"": 74, ""type"": ""Gene_or_gene_product""}, {""token"": ""E2F - 1"", ""start_span"": 93, ""end_span"": 100, ""type"": ""Gene_or_gene_product""}]"
